O

OrbiMed Portfolio holdings

AUM $3.98B
This Quarter Return
+14.59%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$8.71B
AUM Growth
+$8.71B
Cap. Flow
-$1.43B
Cap. Flow %
-16.47%
Top 10 Hldgs %
33.55%
Holding
149
New
15
Increased
27
Reduced
39
Closed
13

Sector Composition

1 Healthcare 93.45%
2 Financials 0.39%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
RCKT icon
76
Rocket Pharmaceuticals
RCKT
$358M
$17.5M 0.2%
1,849,300
+458,300
+33% +$4.34M
FWP
77
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
$16.8M 0.19%
798,000
IMGN
78
DELISTED
Immunogen Inc
IMGN
$16.3M 0.19%
6,095,647
SRPT icon
79
Sarepta Therapeutics
SRPT
$1.98B
$16.1M 0.18%
+261,800
New +$16.1M
ARWR icon
80
Arrowhead Research
ARWR
$3.84B
$15.9M 0.18%
+2,159,973
New +$15.9M
SVA
81
DELISTED
Sinovac Biotech, Ltd
SVA
$15.7M 0.18%
2,667,500
PRQR icon
82
ProQR Therapeutics
PRQR
$256M
$15.4M 0.18%
2,305,446
DERM
83
DELISTED
Dermira, Inc.
DERM
$14.4M 0.16%
+425,600
New +$14.4M
NTRA icon
84
Natera
NTRA
$23B
$14.2M 0.16%
1,276,190
LAB icon
85
Standard BioTools
LAB
$493M
$14M 0.16%
1,746,100
AET
86
DELISTED
Aetna Inc
AET
$13.5M 0.15%
116,600
PVLA
87
Palvella Therapeutics, Inc. Common Stock
PVLA
$592M
$13.3M 0.15%
7,259,620
BCR
88
DELISTED
CR Bard Inc.
BCR
$13M 0.15%
58,000
+35,000
+152% +$7.85M
DBVT
89
DBV Technologies
DBVT
$249M
$12.6M 0.14%
+345,700
New +$12.6M
IMMU
90
DELISTED
Immunomedics Inc
IMMU
$12.4M 0.14%
3,802,000
RARE icon
91
Ultragenyx Pharmaceutical
RARE
$3.04B
$12M 0.14%
169,300
SNDX icon
92
Syndax Pharmaceuticals
SNDX
$1.39B
$11.5M 0.13%
757,365
STDY
93
DELISTED
SteadyMed Ltd
STDY
$11M 0.13%
+3,072,196
New +$11M
SAGE
94
DELISTED
Sage Therapeutics
SAGE
$10.8M 0.12%
+235,400
New +$10.8M
ASMB icon
95
Assembly Biosciences
ASMB
$183M
$10.1M 0.11%
1,397,100
AFMD
96
DELISTED
Affimed
AFMD
$9.38M 0.11%
3,375,000
-400,000
-11% -$1.11M
NBRV
97
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$9.27M 0.11%
1,315,000
SYRE icon
98
Spyre Therapeutics
SYRE
$1.02B
$8.72M 0.1%
1,360,224
CLLS
99
Cellectis
CLLS
$260M
$8.43M 0.1%
350,000
PTLA
100
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$8.42M 0.1%
370,900